Disciplined Investments’s Integra LifeSciences IART Stock Holding History

Disciplined Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13	Closed	-$535	–	761
2023 Q2	$535	Sell	13 -2	-13%	-$96	﹤0.01%	1206
2023 Q1	$861	Buy	15 +2	+15%	+$113	﹤0.01%	1023
2022 Q4	$729	Buy	13 +6	+86%	+$305	﹤0.01%	1029
2022 Q3	$0	Sell	7 -5	-42%	-$256	﹤0.01%	1389
2022 Q2	$1K	Hold	12	–	–	﹤0.01%	965
2022 Q1	$1K	Buy	+12	New	+$790	﹤0.01%	1024

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Disciplined Investments's IART Position: Q3 2023 in Review

Disciplined Investments sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 13 shares — an estimated $535 sold.

Disciplined Investments first reported a position in IART in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

Disciplined Investments reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
Disciplined Investments sold 13 Integra LifeSciences shares in Q3 2023, an estimated $535.
Disciplined Investments first reported a position in Integra LifeSciences in Q1 2022 and held it in 6 quarters.
Disciplined Investments's Integra LifeSciences position peaked at $1K in Q2 2022.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.